Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma

Fig. 2

Relative miR-197 expression level based on clinicopathologic variables and progression status. Relative miR-197 expression levels did not differ based on Hans classification (a), EBV infection (b), primary site (c) or Ann Arbor stage (d) in the full cohort of diffuse large B-cell lymphoma (n = 51). MiR-197 levels tended to be reduced in the progression group compared with the no progression group in the full cohort (n = 51) (e). In the R-CHOP cohort (n = 43), miR-197 was significantly reduced in the progression group (f)

Back to article page
\